Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
or 7 9 7 9 O
older 10 15 10 15 O

Eligible 0 8 16 24 O
for 9 12 25 28 O
HCV 13 16 29 32 B-treatment
treatment 17 26 33 42 I-treatment
per 27 30 43 46 O
2016 31 35 47 51 O
AASLD 36 41 52 57 O
/ 41 42 57 58 O
IDSA 42 46 58 62 O
guidelines 47 57 63 73 O

Health 0 6 74 80 O
care 7 11 81 85 O
provider 12 20 86 94 O
decision 21 29 95 103 O
to 30 32 104 106 O
treat 33 38 107 112 O
patient 39 46 113 120 O
with 47 51 121 125 O
Zepatier 52 60 126 134 B-treatment
- 60 61 134 135 I-treatment
based 61 66 135 140 I-treatment
therapy 67 74 141 148 I-treatment
with 75 79 149 153 O
or 80 82 154 156 O
without 83 90 157 164 O
ribavirin 91 100 165 174 B-treatment
based 101 106 175 180 O
on 107 109 181 183 O
2016 110 114 184 188 O
AASLD 115 120 189 194 O
/ 120 121 194 195 O
IDSA 121 125 195 199 O
guidelines 126 136 200 210 O

Known 0 5 211 216 O
hypersensitivity 6 22 217 233 O
( 23 24 234 235 O
allergy 24 31 235 242 O
) 31 32 242 243 O
to 33 35 244 246 O
elbasvir 36 44 247 255 B-allergy_name
, 44 45 255 256 O
grazoprevir 46 57 257 268 B-allergy_name
, 57 58 268 269 O
or 59 61 270 272 O
ribavirin 62 71 273 282 B-allergy_name

Using 0 5 283 288 O
illicit 6 13 289 296 O
drugs 14 19 297 302 O
( 20 21 303 304 O
either 21 27 304 310 O
opiates 28 35 311 318 O
, 35 36 318 319 O
cocaine 37 44 320 327 O
, 44 45 327 328 O
or 46 48 329 331 O
benzodizepenes 49 63 332 346 O
) 63 64 346 347 O
within 65 71 348 354 O
the 72 75 355 358 O
last 76 80 359 363 B-upper_bound
6 81 82 364 365 I-upper_bound
months 83 89 366 372 I-upper_bound

Willing 0 7 373 380 O
to 8 10 381 383 O
receive 11 18 384 391 O
HCV 19 22 392 395 B-treatment
treatment 23 32 396 405 I-treatment
on 33 35 406 408 O
- 35 36 408 409 O
site 36 40 409 413 O
at 41 43 414 416 O
DoSA 44 48 417 421 O
clinics 49 56 422 429 O

